EVP and President, BioPharmaceuticals Business Unit, AstraZeneca
Ruud Dobber was appointed Executive Vice President (EVP) and President, BioPharmaceuticals Business Unit in January 2019 and is responsible for product strategy and commercial delivery for Cardiovascular, Renal & Metabolism (CVRM) and Respiratory diseases. Prior to this, Ruud held...
Read More →